J&J’s Opioid Settlement Finalized; ADHD & Hoarding; Walking to Fight Alzheimer’s

Johnson & Johnson, along with three other big name drug distributors, reached a final $26 billion settlement over their role in the national opioid crisis. (ABC News)

According to a systematic review and meta-analysis, people with mood and anxiety disorders were more likely to modify their behavior in response to punishments than those without. (JAMA Psychiatry)

Hoarding disorder was linked with attention deficit/hyperactivity disorder in an 88-person study of mostly older females. (ScienceDaily)

In a new scientific brief released by the World Health Organization, there was a 25% increase in the global prevalence of anxiety and depression during the first year of the pandemic. “The information we have now about the impact of COVID-19 on the world’s mental health is just the tip of the iceberg,” said WHO Director-General Tedros Adhanom Ghebreyesus, PhD, MSc, in a statement.

One easy way to cut Alzheimer’s risk by 33%? Briskly walking for at least 2.5 hours a week. (New York Post)

A new 16-question “Washington Early Recognition Center Affectivity and Psychosis” screening tool demonstrated 78% accuracy in identifying young people at high risk for schizophrenia and who may go on to develop the illness. “It is self-administered, only takes a few minutes to complete and is very good at quickly identifying those who require clinical evaluation for emerging psychosis,” said Daniel Mamah, MD, of Washington University School of Medicine in St. Louis, in a statement. (Schizophrenia Research)

New data from the Oregon Health Authority indicated that many of the state’s residents said they’re interested in taking psilocybin for general well-being rather than for anxiety or depression. (Oregon Public Broadcasting)

No, crack pipes are not part of the proposed overdose prevention program announced by the Biden administration, as some have argued. (New York Times)